Cubist Systematic Strategies’s Anavex Life Sciences AVXL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-50,993	Closed	-$475K	–	3704
2023 Q4	$475K	Buy	+50,993	New	+$351K	﹤0.01%	2551
2023 Q1	–	Sell	-119,600	Closed	-$1.11M	–	3894
2022 Q4	$1.11M	Sell	119,600 -5,872	-5%	-$62.7K	0.01%	2350
2022 Q3	$1.29M	Buy	125,472 +91,979	+275%	+$971K	0.01%	2402
2022 Q2	$335K	Sell	33,493 -23,787	-42%	-$225K	﹤0.01%	3357
2022 Q1	$705K	Buy	57,280 +46,888	+451%	+$577K	0.01%	2298
2021 Q4	$180K	Sell	10,392 -4,000	-28%	-$76K	﹤0.01%	3064
2021 Q3	$258K	Sell	14,392 -23,596	-62%	-$470K	﹤0.01%	2442
2021 Q2	$868K	Buy	37,988 +27,158	+251%	+$402K	0.01%	1677
2021 Q1	$162K	Buy	+10,830	New	+$118K	﹤0.01%	2536
2020 Q4	–	Sell	-11,684	Closed	-$53K	–	2555
2020 Q3	$53K	Sell	11,684 -6,133	-34%	-$26.4K	﹤0.01%	2360
2020 Q2	$88K	Buy	+17,817	New	+$67.3K	﹤0.01%	2216
2016 Q1	–	Sell	-17,570	Closed	-$98K	–	1601
2015 Q4	$98K	Buy	+17,570	New	+$125K	0.01%	1512